Our Cause

Breast Cancer Facts

In 2013, breast cancer continues to be the most common cancer diagnosis in Canadian women over the age of 20 – with 1 in 4 cancer diagnoses being breast cancer. It is the second leading cause of cancer deaths in Canadian women, after lung cancer.

Fewer Canadian women are dying from breast cancer today than in the past. Breast cancer deaths have decreased by 42 percent since the peak in 1986 due to earlier detection through regular mammography screening, advances in screening technology, and improved treatments. This represents a small, but positive change from 2012 statistics, which quoted a 39 percent reduction in deaths since 1986.

One in 9 Canadian women is expected to develop breast cancer during her lifetime (by the age of 90). One in 29 Canadian women will die from breast cancer. These statistics remain unchanged over the past year. For more information about breast cancer in Canada, please click here.


60% of the funds raised by ONERUN will support The Massel-Cruickshank Breast Cancer Patient Assistance Fund that falls under the Patient Assistance Program at LHSC.

20% of the funds raised will support the Breast Care Clinical Research and Tumour Biobank housed within the Lawson Health Research Institute at St. Joseph’s Hospital.

20% of the funds raised will support the ONERUN Education Program - an awareness campaign that supports patients' from diagnosis to prognosis, with emphasis on General Practitioner's role in the journey.

onerun funds

The Patient Assistance Program

Imagine receiving a potentially life-threatening diagnosis like cancer. The situation becomes even worse if you have to worry about trying to manage the costs associated with cancer diagnosis and treatment. The Patient Assistance Program lets patients and their families focus on healing. For more information, click here.

Breast Care Clinical Research and Tumour Biobank

onerun funds

• It’s a first for London, and serves as an important resource to fast tracking discoveries in breast cancer diagnosis, treatment and prevention from the lab to the bedside.

• Every patient with suspected breast cancer is offered an opportunity to donate tissue at the time of their biopsy. It also allows newly diagnosed breast cancer patients the option of taking part in innovative pre-operative clinical trials – before their cancer surgery – that are not typically available elsewhere in Canada.

• The tumour biobank allows for local processing, cataloguing and storage of tissue biopsies and other specimens collected from breast care patients that have expressed an interest in participating and supporting clinical research.

• The tumour biobank is one of many initiatives that is expected to greatly improve the overall journey of breast care based out of the Norton and Lucille Wolf Breast Care Centre at St. Joseph’s Health Care London and on a city-wide basis.